Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.
about
Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infectionPneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.Community-Acquired Pneumonia in HIV-Infected Individuals.Stimulating Evidence for Pneumococcal Conjugate Vaccination Among HIV-Infected Adults.
P2860
Q27023322-D1C3771B-AF4A-4582-B025-1E5771E10AC3Q34452479-A6F727B2-71EF-42ED-B1CC-A229A962FC4AQ38124392-061F5642-EC11-4BE7-B4DC-4C2C19B4B63AQ40560650-12A41F4B-5D82-476A-9B38-63500AB96C68Q41662682-F5BBFE65-3B5B-443B-919C-1AE40456FCDAQ42235608-DE397127-CB7B-4995-A418-B32CFD281E2EQ45979911-E3B448B6-EB97-42E0-8972-8C6E44571A47
P2860
Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serologic response to primary ...... nation antiretroviral therapy.
@en
Serologic response to primary ...... nation antiretroviral therapy.
@nl
type
label
Serologic response to primary ...... nation antiretroviral therapy.
@en
Serologic response to primary ...... nation antiretroviral therapy.
@nl
prefLabel
Serologic response to primary ...... nation antiretroviral therapy.
@en
Serologic response to primary ...... nation antiretroviral therapy.
@nl
P2093
P2860
P356
P1476
Serologic response to primary ...... ination antiretroviral therapy
@en
P2093
Chin-Ting Su
Ching-Lan Lu
Shan-Chwen Chang
Shu-Fang Chang
Sui-Yuan Chang
Wen-Chun Liu
Yi-Ching Su
P2860
P304
P356
10.4161/HV.22836
P577
2013-01-04T00:00:00Z